Do newborns really need a hepatitis B vaccine?
The Claim
The hepatitis B vaccine is unnecessary for newborns.
The Facts
Although the risk of exposure may be low, the consequences of infection can be serious.
The Truth
The hepatitis B vaccine is a safe, well-established way to protect newborns from a rare but serious infection and lifelong complications.
What we're hearing:
The hepatitis B vaccine isn’t necessary for newborns.
What we're hearing:
The hepatitis B vaccine isn’t necessary for newborns.
What's true:
Hepatitis B is often thought of as something spread through behaviors like sexual contact or sharing needles – things that may not seem relevant for a newborn.
Additionally, most pregnant mothers are tested for hepatitis B during pregnancy, which helps identify many cases before birth.
And recently, the government changed the recommendation for this vaccine to invite a conversation between the baby’s family and doctor regarding whether to give the first injection at birth or at 2 months old.
What's missing?
While exposure to hepatitis B may be unlikely, babies who do contract it face serious complications. And newborns can be exposed in ways that people may not expect: testing isn’t perfect, and exposure can happen during birth or shortly after. Without protection, a newborn is especially vulnerable.
There is no known benefit to delaying the vaccine, which has been used for over 35 years and given to millions of newborns with a strong safety record. In fact, it’s a big part of why hepatitis B rates are lower today than in the past.
What's at stake:
If infected early in life, babies have a much higher chance of developing chronic, lifelong infection, which can lead to serious liver disease and more.
There’s also a broader impact: when decisions are driven by incomplete information, it can create uncertainty or distrust that makes it harder for families to confidently protect their children.
Bottom line:
The hepatitis B vaccine at birth is a safe, well-established way to protect newborns during a brief but important window of vulnerability.
References
Centers for Disease Control and Prevention (CDC) Recommendations
American Academy of Pediatrics (AAP) Recommendations
AAP Pediatrics (2026): Birth-dose safety & effectiveness review
Randomized Controlled Trial (Vaccines, 2021)
CDC delay of infant hepatitis B shot likely to raise infections, studies show



